Newsletter Archive

31. 06.29.23 -- Identifying And Mitigating Absorption Risks In Early Drug Development 6/29/2023

    06/29/23 Drug Discovery Online Newsletter

32. 06.27.23 -- Forming Meaningful Pharma-Academia Partnerships 6/27/2023
    06/27/23 Drug Discovery Online Newsletter
33. 06.21.23 -- Manufacturing To The Highest Standards Of Product Quality And Regulatory Compliance 6/21/2023

    06/21/23 Drug Discovery Online Newsletter

34. 06.21.23 -- What Are The Key Enablers For Successful Late-Phase Biologics Development And Launch? 6/21/2023

    06/21/23 Drug Discovery Online Newsletter

35. 06.20.23 -- The Need — And Opportunity — To Develop Broad-Spectrum Antivirals 6/20/2023
    06/20/23 Drug Discovery Online Newsletter
36. 06.13.23 -- 4 Learnings From A Career Of Drug Discovery 6/13/2023
    06/13/23 Drug Discovery Online Newsletter
37. 06.08.23 -- Antibody Variants, Mechanistic Modeling, And High-Throughput Process Development 6/8/2023

    06/08/23 Drug Discovery Online Newsletter

38. 06.07.23 -- Discover The New Possibilities For Increased Dosing Capabilities Offered By Nanoformed APIs 6/7/2023

    06/07/23 Drug Discovery Online Newsletter

39. 06.06.23 -- Leverage An Integrated Drug Substance And Drug Product CMC Strategy 6/6/2023

    06/06/23 Drug Discovery Online Newsletter

40. 06.06.23 -- How To Navigate The Patenting Challenges Of AI-Assisted Drug Discovery 6/6/2023
    06/06/23 Drug Discovery Online Newsletter